Are You Seeking Fast, Dramatic, and Sustained Symptom Relief For Your Polymyalgia?
Treating Polymyalgia Rheumatica
In the past, polymyalgia rheumatica patients and their doctors faced a lack of effective and safely sustainable treatments. But more than 75% of Helen Foundation’s patients with polymyalgia rheumatica have reported an average of 80% symptom relief following Microdose Therapy.
The Trouble With Prednisone
Prednisone is a common treatment for polymyalgia rheumatica. Commonly, it is prescribed in tapering dosages over a few weeks duration. The symptoms usually reduce. But often the polymyalgia rheumatica will return when the prednisone is discontinued, and there is little in the way of a backup plan that works. Repeating the multi-week prednisone treatment means patients run the risk of weight gain, thinning of the skin and weakening of the bones.
Many polymyalgia patients come to us after failed prednisone treatment.
Treating Polymyalgia Rheumatica With Microdose Therapy™
Between 2000 and 2010, 37 patients with the diagnosis of polymyalgia rheumatica were enrolled into the Microdose Therapy Program. The average relief response was 80%. As they started Microdose Therapy, we allowed them to maintain the prescription medicines they were using previous to the study. The 37 patients were treated in many clinics throughout the United States. That way, one clinic could not prejudice the results. NSAIDs are estimated to give an average of 25% relief. Microdose Therapy averaged an additional 80% relief.
Polymyalgia Rheumatica Symptoms
Polymyalgia rheumatica is a disorder marked by widespread muscle aching and stiffness, especially in the neck, shoulders, upper arms, thighs and hips. The onset can be rapid or slow. The symptoms may include:
• anemia • moderate to severe stiffness
• fatigue • fever • weight loss • moderate to severe aching
What is YOUR Polymyalgia Rheumatica Symptom Severity Score?
We measure polymyalgia rheumatica symptom severity using patient-originated numbers to evaluate the effectiveness of Microdose Therapy. Before starting, the patient’s numbers define the baseline. As the patient progresses through the Microdose Therapy program, percent relief from baseline is determined. Try measuring your symptoms like we do. Click to rate each entry from 0 to 10 with 0 representing no problem and 10 severe. Then click for the total score. Mild is less than 20, moderate is 21-40, and severe is greater than 40. If you had started Microdose Therapy with a total score of 100 and it dropped to 20 during the program, you would have achieved 80% relief.